G 30mg 014 (Methylphenidate Hydrochloride Extended-Release (LA) 30 mg)
Pill with imprint G 30mg 014 is Yellow, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release (LA) 30 mg. It is supplied by Granules Pharmaceuticals Inc..
Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for G 30mg 014
Methylphenidate Hydrochloride Extended-Release (LA)
- Imprint
- G 30mg 014
- Strength
- 30 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cns stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Granules Pharmaceuticals Inc.
- National Drug Code (NDC)
- 70010-0014
More about methylphenidate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 878 Reviews
- Drug class: CNS stimulants
- FDA Alerts (3)
Consumer resources
- Patient Information
- Methylphenidate transdermal
- Methylphenidate Oral, Transdermal (Advanced Reading)
- Methylphenidate Transdermal (Advanced Reading)
- Methylphenidate Chewable Tablets
- ... +9 more
- Other brands
- Ritalin, Concerta, Ritalin LA, Adhansia XR, ... +11 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.